The ceramide and sphingoid base backbones of sphingolipids are highly are highly bioactive compounds that affect growth, differentiation, cell migration and apoptosis when added to transformed cells in culture as well as when fed to mice treated when a colon carcinogen or that have a genetic that predisposes them to colon cancer. Based on the mechanisms of action of ceramides and sphingoid bases (and structure-function relationships for the metabolism of these compounds, synthetic analogs have been prepared that are more potent than the naturally compounds when tested against colon cancer cells in culture. This Program will characterize how these compounds are metabolized by cells in cultures and in vivo, as well as to evaluate the effectiveness of additional compounds that will be generated as part of a sphingolipid analog library.
The specific aims will be to: 1) Analyze sphingolipid analogs as substrates/inhibitors of specific enzymatic targets in vitro. 2) Analyze cellular metabolism/effects of the sphingolipid analogs. 3) Analyze sphingolipid analog digestion, uptake and metabolism in vivo. An, 4) Analyze selected sphingolipid analogs for their effects on tumors in animals models for cancer. The findings of these studies will identify the most effective compounds and strategies for use of sphingolipids for the prevention and treatment of colon cancer and, perhaps, other forms of neoplasia.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Program--Cooperative Agreements (U19)
Project #
7U19CA087525-03
Application #
6588116
Study Section
Special Emphasis Panel (ZCA1)
Project Start
2002-04-23
Project End
2002-05-31
Budget Start
Budget End
Support Year
3
Fiscal Year
2001
Total Cost
Indirect Cost
Name
Emory University
Department
Type
DUNS #
042250712
City
Atlanta
State
GA
Country
United States
Zip Code
30322
Acker, Timothy M; Khatri, Alpa; Vance, Katie M et al. (2013) Structure-activity relationships and pharmacophore model of a noncompetitive pyrazoline containing class of GluN2C/GluN2D selective antagonists. J Med Chem 56:6434-56
Symolon, Holly; Bushnev, Anatoliy; Peng, Qiong et al. (2011) Enigmol: a novel sphingolipid analogue with anticancer activity against cancer cell lines and in vivo models for intestinal and prostate cancer. Mol Cancer Ther 10:648-57
Pruett, Sarah T; Bushnev, Anatoliy; Hagedorn, Kerri et al. (2008) Biodiversity of sphingoid bases (""sphingosines"") and related amino alcohols. J Lipid Res 49:1621-39
Wang, Hongtao; Maurer, Barry J; Liu, Yong-Yu et al. (2008) N-(4-Hydroxyphenyl)retinamide increases dihydroceramide and synergizes with dimethylsphingosine to enhance cancer cell killing. Mol Cancer Ther 7:2967-76
Morales, Pablo R; Dillehay, Dirck L; Moody, Steven J et al. (2007) Safingol toxicology after oral administration to TRAMP mice: demonstration of safingol uptake and metabolism by N-acylation and N-methylation. Drug Chem Toxicol 30:197-216
Dougherty, Ann M; McDonald, Frank E; Liotta, Dennis C et al. (2006) Synthesis of 1-deoxysphingosine derivatives with conformationally restricted pyrrolidinediol head groups. Org Lett 8:649-52
Zheng, Wenjing; Kollmeyer, Jessica; Symolon, Holly et al. (2006) Ceramides and other bioactive sphingolipid backbones in health and disease: lipidomic analysis, metabolism and roles in membrane structure, dynamics, signaling and autophagy. Biochim Biophys Acta 1758:1864-84
Wiseman, John M; McDonald, Frank E; Liotta, Dennis C (2005) 1-Deoxy-5-hydroxysphingolipids as new anticancer principles: an efficient procedure for stereoselective syntheses of 2-amino-3,5-diols. Org Lett 7:3155-7
Symolon, Holly; Schmelz, Eva M; Dillehay, Dirck L et al. (2004) Dietary soy sphingolipids suppress tumorigenesis and gene expression in 1,2-dimethylhydrazine-treated CF1 mice and ApcMin/+ mice. J Nutr 134:1157-61
Sullards, M C; Wang, E; Peng, Q et al. (2003) Metabolomic profiling of sphingolipids in human glioma cell lines by liquid chromatography tandem mass spectrometry. Cell Mol Biol (Noisy-le-grand) 49:789-97

Showing the most recent 10 out of 11 publications